Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

An ink surgical marker pen is damaging to tendon cells.

Franklin SL, Jayadev C, Poulsen R, Hulley P, Price A.

Bone Joint Res. 2012 Mar 1;1(3):36-40. doi: 10.1302/2046-3758.13.2000032. Print 2012 Mar.

2.

Reduced chondrocyte viability is associated with the use of surgical marker pen ink.

Getgood A, McNamara I, Kili S, Bhullar T, Henson F.

Am J Sports Med. 2011 Jun;39(6):1270-4. doi: 10.1177/0363546510396315. Epub 2011 Feb 18.

PMID:
21335346
3.

Descemet-stripping automated endothelial keratoplasty (DSAEK): effect of nontoxic gentian violet marking pen on DSAEK donor tissue viability by using vital dye assay.

Ide T, Yoo SH, Kymionis GD, Perez VL, Goldman JM, O'Brien TP.

Cornea. 2008 Jun;27(5):562-4. doi: 10.1097/ICO.0b013e318165841f.

PMID:
18520506
4.

Ophthalmic pre-inked marking pad.

Allarakhia L, Thornton SP.

J Cataract Refract Surg. 1991 May;17(3):374-5.

PMID:
1861255
5.

Retained interface gentian violet ink in Descemet stripping endothelial keratoplasty.

Liang SY, Lee GA.

Cornea. 2012 Jan;31(1):92-3. doi: 10.1097/ICO.0b013e31821eea7f.

PMID:
21955633
6.
7.

Precautions with gentian violet: skin marking made sterile, effective, and economical.

Chen TM, Castaneda M, Wanitphakdeedecha R, Nguyen TH, Tarrand JJ, Soares MK.

Am J Infect Control. 2009 Apr;37(3):244-6. doi: 10.1016/j.ajic.2008.06.005. Epub 2008 Oct 14.

PMID:
18922601
8.

Outbreak of diffuse lamellar keratitis caused by marking-pen toxicity.

Hadden OB, McGhee CN, Morris AT, Gray TB, Ring CP, Watson AS.

J Cataract Refract Surg. 2008 Jul;34(7):1121-4. doi: 10.1016/j.jcrs.2008.03.024.

PMID:
18571079
9.

Surgical site markers: potential source of infection.

Driessche AM.

Orthop Nurs. 2012 Nov-Dec;31(6):344-7. doi: 10.1097/NOR.0b013e3182742609.

PMID:
23168939
10.

Diffuse lamellar keratitis after laser in situ keratomileusis associated with surgical marker pens.

Rosman M, Chua WH, Tseng PS, Wee TL, Chan WK.

J Cataract Refract Surg. 2008 Jun;34(6):974-9. doi: 10.1016/j.jcrs.2008.02.014.

PMID:
18499004
11.

The surgical marking pen: a comparative study.

Stromberg BV.

Plast Reconstr Surg. 1987 Jul;80(1):104-7.

PMID:
3602148
12.

[BTB allograft for revision surgery of the anterior cruciate ligament - part 2].

Musil D, Sadovský P, Stehlík J.

Acta Chir Orthop Traumatol Cech. 2005;72(5):297-303. Czech.

PMID:
16316605
14.

Mycobacterium chelonae wound infections after plastic surgery employing contaminated gentian violet skin-marking solution.

Safranek TJ, Jarvis WR, Carson LA, Cusick LB, Bland LA, Swenson JM, Silcox VA.

N Engl J Med. 1987 Jul 23;317(4):197-201.

PMID:
3600710
15.

Current practice on preoperative correct site surgical marking.

Masud D, Moore A, Massouh F.

J Perioper Pract. 2010 Jun;20(6):210-4.

PMID:
20586361
16.

Acute toxicity of marking pen emissions.

Anderson RC, Anderson JH.

J Toxicol Environ Health A. 2003 May 9;66(9):829-45.

PMID:
12746130
18.

Effect of marking pens on femtosecond laser-assisted flap creation.

Ide T, Kymionis GD, Abbey AM, Yoo SH, Culbertson WW, O'Brien TP.

J Cataract Refract Surg. 2009 Jun;35(6):1087-90. doi: 10.1016/j.jcrs.2009.01.021.

PMID:
19465296
19.

Does ink age inside of a pen cartridge?

Grim DM, Siegel J, Allison J.

J Forensic Sci. 2002 Nov;47(6):1294-7.

PMID:
12455652
20.

Tendon repair through stem cell intervention: cellular and molecular approaches.

Bullough R, Finnigan T, Kay A, Maffulli N, Forsyth NR.

Disabil Rehabil. 2008;30(20-22):1746-51. doi: 10.1080/09638280701788258. Review.

PMID:
18720123
Items per page

Supplemental Content

Write to the Help Desk